GNRH1 and ovarian hyperstimulation syndrome: Although the first Cochrane review comparing the two stimulation protocols did not find significant differences in the incidence of OHSS [11], more recent meta-analyses clearly demonstrated that GnRH antagonists were associated with a significant reduction in the incidence of severe OHSS and, thus, the hospitalization rate [12,13].